Differential diagnosis between intraductal papillary mucinous neoplasm with an associated invasive carcinoma and pancreatic ductal adenocarcinoma on ultrasonography: the utility of echo intensity and contrast enhancement

다국어 초록 (Multilingual Abstract)

Purpose: The aim of this study was to investigate the utility of echo intensity and contrast enhancement in the differential diagnosis between intraductal papillary mucinous neoplasm with an associated invasive carcinoma (IPMN-IC) and pancreatic ductal adenocarcinoma (PDAC) on ultrasonography.
Methods: This study included eight and 37 patients who had pathologically confirmed IPMN-IC and PDAC, respectively, and were enrolled for a comparative analysis of the sonographic features of the tumors. In the quantitative echo intensity evaluation, the two groups were compared with respect to the difference between the tumor intensity and the pancreatic intensity (TI-PI) and between the tumor intensity and the vascular intensity (TI-VI). In the quantitative contrast enhancement evaluation, the increase in echo intensity (ΔTI) and increase in echo intensity per unit of time (slope) were compared between the groups. The echo intensity and contrast enhancement were also compared between the two groups in patients with T3-T4 disease. In addition, the correlations of the histological type, tumor size, stromal type, and T factor with echogenicity and contrast enhancement were analyzed.
Results: IPMN-IC had significantly greater echo intensity and contrast enhancement than PDAC (TI-PI, P=0.004; TI-VI, P=0.001; ΔTI, P=0.012; slope, P=0.002). In T3-T4 disease, IPMN-IC also showed greater echo intensity and faster enhancement than PDAC. Echo intensity and contrast enhancement were correlated with histological type (TI-PI, P=0.003; TI-VI, P<0.001; ΔTI, P=0.007; slope, P<0.001).
Conclusion: IPMN-IC and PDAC can be differentiated by the quantitative evaluation of echo intensity and contrast enhancement.

참고문헌 (Reference)

1 Sakamoto H, "Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas" 34 : 525-532, 2008

2 Kamitani K, "Ultrasonographic findings of invasive micropapillary carcinoma of the breast: correlation between internal echogenicity and histological findings" 19 : 349-352, 2012

3 Pezzilli R, "Three-dimensional contrast-enhanced ultrasonography of intraductal papillary mucinous neoplasms of the pancreas:a comparison with magnetic resonance imaging" 42 : 1164-1168, 2013

4 Woo SM, "Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma" 36 : 50-55, 2008

5 Sakamoto H, "Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm" 15 : 5489-5492, 2009

6 D'Onofrio M, "Resectable pancreatic adenocarcinoma: is the enhancement pattern at contrast-enhanced ultrasonography a preoperative prognostic factor?" 35 : 1929-1937, 2009

7 Rahib L, "Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States" 74 : 2913-2921, 2014

8 Maire F, "Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection: comparison with pancreatic ductal adenocarcinoma" 51 : 717-722, 2002

9 Yamaguchi K, "Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN" 40 : 571-580, 2011

10 Tada M, "Pancreatic cancer in patients with pancreatic cystic lesions:a prospective study in 197 patients" 4 : 1265-1270, 2006

11 Quaia E, "Microbubble ultrasound contrast agents: an update" 17 : 1995-2008, 2007

12 Ohno E, "Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrastenhanced endoscopic ultrasonography morphological changes:focus on malignant transformation of intraductal papillary mucinous neoplasm itself" 41 : 855-862, 2012

13 Murakami Y, "Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma" 100 : 13-18, 2009

14 Shimada K, "Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma" 32 : 281-287, 2006

15 Sohn TA, "Intraductal papillary mucinous neoplasms of the pancreas:an updated experience" 239 : 788-797, 2004

16 Malvezzi M, "European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?" 26 : 779-786, 2015

17 Park JS, "Effectiveness of contrast-enhanced harmonic endoscopic ultrasound for the evaluation of solid pancreatic masses" 20 : 518-524, 2014

18 Kitano M, "Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography" 53 : 854-859, 2004

19 Nishida M, "Does contrast-enhanced ultrasound reveal tumor angiogenesis in pancreatic ductal carcinoma? A prospective study" 35 : 175-185, 2009

20 Sofuni A, "Differential diagnosis of pancreatic tumors using ultrasound contrast imaging" 40 : 518-525, 2005

21 Harima H, "Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography" 21 : 6252-6260, 2015

22 Uehara H, "Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas" 57 : 1561-1565, 2008

23 Ozawa Y, "Contrast-enhanced sonography of small pancreatic mass lesions" 21 : 983-991, 2002

24 Takeshima K, "Comparison of IV contrast-enhanced sonography and histopathology of pancreatic cancer" 185 : 1193-1200, 2005

25 Kitano M, "Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography" 107 : 303-310, 2012

26 Egawa S, "A digest of the Pancreatic Cancer Registry Report 2007" 23 : 105-123, 2008